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Abstract
Background: Twelve populations of E. coli were serially propagated for 20,000 generations in a
glucose-supplemented minimal medium in order to study the dynamics of evolution. We sought to
find and characterize one of the beneficial mutations responsible for the adaptation and other
phenotypic changes, including increased cell size, in one of these populations.
Results: We used transposon-tagging followed by P1-transduction into the ancestor, screening for
increased cell size and fitness, co-transduction analysis, and DNA sequencing. We identified a 1-bp
insertion in the BoxG1 region located upstream of glmUS, an operon involved in cell-wall
biosynthesis. When transduced into the ancestor, this mutation increased competitive fitness by
about 5%. This mutation spread through its population of origin between 500 and 1500 generations.
Mutations in this region were not found in the other 11 evolving populations, even after 20,000
generations.
Conclusion: The 1-bp insertion in the BoxG1 region near glmUS was demonstrably beneficial in
the environment in which it arose. The absence of similar mutations in the other evolved
populations suggests that they substituted other mutations that rendered this particular mutation
unimportant. These results show the unpredictability of adaptive evolution, whereas parallel
substitutions at other loci in these same populations reveal the predictability.
Background
Evolutionary change involves a fundamental tension
between chance and necessity [1]. On the one hand,
mutations that produce heritable variation occur at ran-
dom, although rates may be modulated by genetic and
environmental factors [2]. On the other hand, natural
selection tends systematically to increase the frequency of
those mutants with phenotypic properties that are useful
in a particular environment. How these forces play out in
time has been the subject of important speculation [3,4]
but is difficult to address empirically.
One approach that can rigorously address the interplay
between chance and necessity is experimental evolution,
especially using microorganisms. In particular, one can
examine the evolution of populations founded from the
same ancestral genotype and propagated under identical
environmental conditions. Unlike experiments with
plants and animals, an evolving population can be
founded from a single haploid individual, such that there
is no shared genetic variation (identical by descent) that
would tend to exaggerate parallel changes. Several recent
studies with viruses and bacteria have demonstrated strik-
ing examples of parallel genetic changes, affecting the
same loci and sometimes even the same base-pair, that
evidently confer fitness benefits [5-15]. Some of these
studies have also found mutations that are present in only
one of the replicate populations, but without construction
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and analysis of isogenic clones it is unclear whether these
unique mutations are beneficial or, alternatively, are neu-
tral or even deleterious mutations that hitchhiked with
beneficial mutations.
In the longest running evolution experiment with micro-
organisms, 12 populations of Escherichia coli B have been
serially propagated in a glucose-supplemented minimal
medium for tens of thousands of generations [16-18].
During this time, the average competitive fitness increased
by ~75% relative to the ancestor [18], the average cell vol-
ume substantially increased [17-21], and many other phe-
notypic changes occurred [11,12,18,22,23]. A number of
mutations have been found in these populations by RFLP
screening using IS elements as probes [24,25] as well as by
random, targeted, and whole-genome sequencing
[11,12,21-23,26-28]. Some of these mutations have been
demonstrated to be beneficial in the experimental envi-
ronment by constructing and competing clones that differ
only by a single mutation [reviewed in 28]. In most cases,
those genes bearing mutations that were demonstrated to
be beneficial also harboured mutations in multiple repli-
cate populations. These parallel mutations affected the
same genes, but they were not usually identical at the
sequence level.
The primary goals of the present paper are to identify a
beneficial mutation based on its advantageous effect; and
then to determine whether the same or similar mutations
were substituted in the replicate evolved populations. Our
strategy was as follows. Using an evolved clone, we made
a pool of clones each carrying a randomly inserted
marker. We then used this entire pool as donors, and
transduced the marker and linked genes into the ancestor.
Next, the resulting transductants were tested for increased
cell size and competitive fitness. A clone with both prop-
erties served as a donor for a second round of transduc-
tion, in order to estimate the physical distance between its
marker and the beneficial mutation of interest. We then
sequenced the relevant regions to find any mutations. We
found two mutations, one of which was previously
unknown. We also sequenced the same region in clones
from samples that were stored at various times to charac-
terize the dynamics of this mutation in the focal popula-
tion. Finally, we sequenced this region in clones from the
replicate populations to determine whether the same or
similar mutations had been substituted in them.
Results
Finding a transduced clone that carries a beneficial 
mutation
REL4548 is a clone that was isolated after evolving for
10,000 generations in a constant environment. From
REL4548, we produced a mix of 1296 insertion mutants,
each carrying a Tn10 mini-transposon that confers resist-
ance to tetracycline. A P1 lysate was then made from that
mixture of insertion mutants, and the lysate was used to
transduce the ancestral strain, REL606 (see Methods for
details). The total pool of transductants was propagated
for 7 days (~47 generations) in the same environment in
which the long-term evolution experiment was con-
ducted. This procedure should increase the frequency of
beneficial transductants that were initially present in the
pool, but the period is too short to allow significant de
novo evolution. In the long-term experiment itself, the
first increases in fitness were discerned around generation
200, and their magnitudes were consistent with muta-
tions having about a 10% fitness advantage [16,17]. The
7-day enrichment of a mutation that confers a 10%
advantage should increase its relative frequency by about
25-fold, and smaller effect mutations would be enriched
to a lesser extent. Therefore, this approach is more likely
to find beneficial mutations with large effects than those
with small effects. To identify beneficial transductants we
first screened for larger cell size, which has been shown to
be strongly correlated with higher fitness in that environ-
ment [17-19]. Measurements of cell size are easier than
measurements of relative fitness, which means that more
transductants can be screened for the former than for the
latter. Those transductants with increased average cell size
were then subsequently tested for improved fitness.
The average cell volume of the ancestral clone at station-
ary phase was measured as between 0.37 and 0.39 fl.
Among the enriched transductant pool, there was a sec-
ond mode in the cell-volume distribution centred around
0.43 fl. We initially chose ten clones that had average cell
volumes of ≥0.44 fl, and we measured the competitive fit-
ness of each relative to the ancestor. Of these, three clones
were then chosen for further study because each one
exhibited a statistically significant increase in fitness.
Southern hybridization analyses further showed that
these three candidates had the same transposon insertion
and hence were progeny of the same transduced clone.
One of them, designated REL10247, was chosen for fur-
ther characterization.
Co-transduction analysis of the transposon and the 
beneficial mutation
Our next challenge was to locate the beneficial mutation
linked to the mini-transposon insertion. P1-transduction
can move as much as ~2% of the bacterial chromosome;
thus, the beneficial mutation could lie as far away as
100,000 bp from the inserted transposon. To get some
idea of the distance between the transposon-encoded Tetr
marker and the beneficial mutation, we examined the co-
transduction of the resistance marker and increased cell
size, using REL10247 as the donor and the ancestor as the
recipient.
The average cell volumes were measured for over 300 Tetr
transductants, and 91.5% produced large cell sizes con-BMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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sistent with co-transduction. Based on the relationship
between co-transduction frequency and physical distance
[29], using 9.66 × 104 bp as the length of the transducing
DNA [29] and 4.6 × 106 bp for the genome size [30], this
frequency predicts a distance of about 2800 bp between
the beneficial mutation and the inserted transposon.
Identification and fitness effect of the beneficial mutation
The second piece of information necessary to locate the
beneficial mutation was to map the inserted mini-trans-
poson. Genomic DNA from the REL10247 clone was
digested with AvaI and shotgun-cloned into pUC19. A Tetr
colony was chosen, the plasmid isolated, and the inserted
fragment was sequenced with standard M13/pUC forward
and reverse sequencing primers. The sequence corre-
sponded to the 3' end of the glmUS  operon. Another
primer was then used to sequence the junction between
the mini-transposon and the E. coli genome. These data
showed that the transposon had inserted just beyond the
glmUS operon, 20 bp downstream from the final amino
acid of the GlmS protein.
Four sets of partially overlapping primer pairs were
designed to amplify ~3000 bp of DNA each. Using these
primers, DNA was sequenced from both the ancestor and
the 10,000-generation clone from which REL10247 was
derived, and new primers were synthesized using the 3'
end of the sequence to walk along each fragment. Using
this approach, we sequenced ~12,000 bp total, about half
on each side of the transposon insertion. Only one differ-
ence between the ancestor and evolved clone was found in
this entire region, a 1-bp adenine insertion in a homopol-
ymeric tract of seven existing adenines. This tract is in a
NagC protein-binding site, called BoxG1, near the glmUS
P1 promoter [31] (Figure 1). The glmUS operon encodes
two proteins: GlmS converts fructose-6-phosphate
(Fru6P) to glucosamine-6-phosphate (GlcN6P); GlmM
(not part of the operon) converts GlcN6P to glucosamine-
1-phosphate (GlcN1P); and GlmU, a bi-functional
enzyme, converts GlcN1P via two reactions to uracil-
diphosphate-N-acetyl-glucosamine (UDP-GlcNAc), a pre-
cursor in the syntheses of both peptidoglycan and
lipopolysaccharides [32,33] (Figure 2). The 1-bp insertion
mutation is 3443 bp from the inserted mini-transposon,
which agrees well with the 2.8 Kb predicted by the co-
transduction analysis. We refer henceforth to this muta-
tion as BoxG18A in recognition of the insertion of an
eighth adenine in the tract.
To demonstrate conclusively that the BoxG18A mutation
in glmUS was responsible for the fitness increase of the
REL10247 strain, we moved that mutation into the ances-
tor using the gene gorging method [34] to make strain
TC640. This strain had a fitness of 1.05 ± 0.01 (95% con-
fidence interval) relative to the ancestor. This advantage
was somewhat less than measured for strain REL10247
itself, suggesting that REL10247 contains one or more
additional beneficial mutations. By screening REL10247
for known beneficial mutations in the vicinity of glmUS,
we found that it also has a deletion of the majority of the
rbs operon, which was previously shown to confer a fit-
ness benefit of ~1.5% [11].
The beneficial BoxG18A mutation presumably alters bind-
ing of the transcription factor NagC to the BoxG1 region.
The NagC protein acts as a transcriptional repressor for the
nagE-BACD and manXYZ operons, but as a transcriptional
activator for the glmUS genes [31,35,36]. NagC binds to
elements associated with two promoters of the glmUS
operon: BoxG1 located next to the proximal promoter P1,
and BoxG2 located upstream of the distal promoter P2
[31]. P1 activity is stimulated by growth on glucose,
whereas P2 activity is fairly constant across a range of con-
ditions. NagC binding is required for activation of the P1
promoter [31]. NagC binds to a 23-bp consensus
sequence [31,35,37-39] (Figure 3). Mutagenesis studies
have shown that the most important bases for NagC bind-
ing to Box elements are the G or C bases at the -11 and +11
locations, and two conserved T bases at positions -5 and -
6 [40]. Positions +4 thru +10 are AT rich, and the adenine
insertion occurs in this region. If this insertion is viewed
as shifting the BoxG1 sequence to the left, then the T at
position -5 is changed to a C (Figure 3). Alternatively, if
the extra adenine is viewed as shifting the sequence to the
right, then the near-consensus G at position +11 is
replaced by a T. In either case, it seems likely that the
insertion reduces binding of the NagC activator to BoxG1,
thereby reducing glmUS expression from the P1 promoter
during growth on glucose.
Region upstream of glmUS, including site of beneficial muta- tion Figure 1
Region upstream of glmUS, including site of beneficial 
mutation. NagC binds to two 23-bp BoxG elements shown 
in bold. The beneficial adenine insertion was in a tract of 
seven existing adenines in BoxG1; it is shown above the 
sequence as +A. The Shine-Dalgarno sequence (S-D) and the 
-10 and -35 regions of two promoters, P1 and P2, are under-
lined. Figure modified from Plumbridge [31].BMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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Biochemical pathways involving GlmS and GlmU Figure 2
Biochemical pathways involving GlmS and GlmU. Biochemical pathways involving GlmS and GlmU, along with certain 
transport and biosynthetic reactions. Not all participating molecules are shown for every reaction. Genes encoding relevant 
enzymes are indicated next to the reactions. Genes printed in bold, and next to reactions shown as heavier arrows, are regu-
lated by NagC. The dashed horizontal line represents the cell envelope. Dashed arrows indicate multiple steps. This figure is a 
composite of information from several sources [31-33,41,59].BMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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To evaluate how this mutation affected glmUS expression,
we examined data from a previous experiment [12] that
measured, with four-fold replication, genomic expression
profiles for the ancestor and for evolved clones from gen-
erations 2000, 10,000 and 20,000 in the same population
that we used to isolate the BoxG18A mutation. As shown
below, the BoxG18A mutation arose prior to generation
2000. The expression profiles were obtained for cells that
were growing exponentially in the same glucose medium
and other conditions of the long-term experiment. In all
24 comparisons between ancestral and evolved clones (4
replicates × 3 generations × 2 genes), the standardized
expression (adjusted for total mRNA) was lower in the
evolved clone, a pattern that is extremely unlikely by
chance alone. The magnitude of the reduction was ~9%
for both glmU and glmS, and at all three time points. These
data therefore support the hypothesis that the BoxG18A
mutation caused a subtle, but significant, reduction in the
expression of glmUS during growth on glucose. Such a
physiological change is also consistent with the reduced
demand for peptidoglycan and lipopolysaccharide, rela-
tive to other cell constituents, in larger cells based on the
geometry of surface area to cell volume.
Fitness effects of the BoxG18A mutation in different media
The BoxG18A mutation is clearly beneficial in glucose,
where the mutation evidently reduces binding of NagC to
the BoxG1 site and thereby reduces expression of the
glmUS operon. To examine further this allele's physiolog-
ical effects, we performed competitions in the same mini-
mal medium but replacing glucose with other substrates
chosen for their relationships to glmUS and NagC.
First, the BoxG18A mutation has no significant effect dur-
ing competition for UDP-GlcNAc, which is the end prod-
uct of GlmS and GlmU activities (Figure 2). The fitness of
TC640, which contains only the BoxG18A mutation on the
ancestral background, relative to the ancestor in medium
containing UDP-GlcNAc is 0.99 ± 0.03 (95% confidence
interval). The absence of any effect is not surprising
because UDP-GlcNAc is biochemically downstream of the
glmUS operon.
Second, the BoxG18A allele is significantly advantageous
in GlcN6P, which is a product of GlmS and is converted
to GlcN1P before being a substrate for GlmU (Figure 2).
The fitness of TC640 relative to the ancestor in medium
containing GlcN6P is 1.15 ± 0.09 (95% confidence inter-
val). At first glance, this advantage might suggest that
expression of glmUS is increased in this case. Alternatively,
GlcN6P can be converted by the nagB-encoded deaminase
to F6P [41], which can be catabolised through the glyco-
lytic pathway. GlmS acts in the opposing direction to cov-
ert Fru6P to GlcN6P for the production of cell-wall
constituents. Hence, a reduction in glmUS  expression
caused by the BoxG18A allele may provide an advantage in
GlcN6P by better balancing metabolic flux between cata-
bolic and anabolic processes. We note, however, that this
hypothesis is further complicated by the observation that
GlcN6P interacts directly with NagC to reduce its affinity
for at least some binding sites [42]. Third, and consistent
with this second hypothesis for the advantage of BoxG18A
in GlcN6P, the BoxG18A allele confers a significant benefit
in competition for fructose, which is also catabolized to
Fru6P. The fitness of TC640 relative to the ancestor in
medium containing fructose as the sole carbon source is
1.06 ± 0.03 (95% confidence interval).
Fourth, the BoxG18A mutation confers a small but signifi-
cant disadvantage during competition for glucosamine
(GlcN). The fitness of TC640 relative to the ancestor in
medium with GlcN as the sole source of carbon is 0.95 ±
0.02 (95% confidence interval). GlcN enters the cell via
the PTS, which converts it to GlcN-6-phosphate [41]. By
contrast, GlcN6P enters the cell via a permease that func-
tions for many phosphorylated sugars [41]. The finding
that the BoxG18A allele is detrimental in GlcN while ben-
eficial in GlcN6P suggests some effect on transport, pre-
sumably mediated by NagC and its interaction with the
BoxG1 site. GlcN enters the cell via two different PTS
enzymes: IIGlc encoded by ptsG, and IIMan encoded by
manY (ptsM) [41]. The latter route is the main one [36].
NagC is a repressor of the manXYZ operon as well as of the
nagE-BACD operon [36]. Thus, NagC represses its own
synthesis, although it also has constitutive promoters that
Effect of BoxG18A mutation on NagC binding sequence Figure 3
Effect of BoxG18A mutation on NagC binding 
sequence. The consensus sequence, including alternative 
bases at some sites, for a 23-bp NagC-binding Box element is 
shown at the top [31]. The four underlined bases are the 
only ones that are invariant across all such elements [31], and 
mutagenesis has shown that these four are also the most 
important for binding NagC [38]. The next row shows the 
ancestral BoxG1 sequence. The bottom two rows show the 
effect of inserting an extra adenine, as in the evolved 
BoxG18A allele, when viewed as shifting the sequence either 
to the left or to the right. The former eliminates the invariant 
T at position -5. The latter removes agreement with the con-
sensus at position +11.BMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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stabilize its expression [36]. Given these interactions, it is
unclear exactly how the feedback would impose a disad-
vantage to the BoxG18A  allele in medium containing
GlcN, but clearly the potential exists for complex regula-
tory effects. One possibility is that the reduced binding of
NagC to the mutant BoxG1 site leaves more NagC to bind
to the manXYZ operator, thereby slightly repressing it and
impeding GlcN transport and catabolism. The growth rate
of E. coli in GlcN has been shown to be limited by trans-
port, and so any decrease in manY  expression might
reduce fitness [43]. Fifth, and consistent with this last
hypothesis, the BoxG18A allele is slightly disadvantageous
in competition for mannose, which is also taken up
through the IIMan PTS system. The fitness of TC640 relative
to the ancestor in mannose medium is 0.97 ± 0.02 (95%
confidence interval).
We must emphasize that the possible explanations sug-
gested above for the fitness effects of the BoxG18A allele in
various media are hypotheses, not conclusions. We would
welcome further biochemical and molecular studies of
this mutation, and others like it, that might confirm or
refute these hypotheses.
Substitution dynamics of the beneficial mutation
To better understand the evolutionary dynamics of the
BoxG18A  mutation, we sought to determine when it
appeared in the evolving population and the time course
of its substitution. The clone from which REL10247 was
derived was isolated at generation 10,000. Preliminary
sequencing of the BoxG1 region from samples taken at
earlier times indicated that the mutation was spreading
between 500 and 1500 generations. We therefore chose
many clones at random from the population samples that
had been stored at generations 500, 1000, and 1500 gen-
erations, and we sequenced the BoxG1 region in each.
None of 51 clones from generation 500 had the BoxG18A
mutation, whereas 14/31 (45%) clones carried it at gener-
ation 1000, and 29/30 (97%) clones had this mutation at
generation 1500.
In an evolving asexual population, the actual rate of
spread of a beneficial mutation is often slower than
expected from its selective advantage. This discrepancy
arises from a phenomenon called clonal interference,
whereby a clone with a particular beneficial mutation
must compete with clones bearing other beneficial muta-
tions [27,44-46]. The decelerating effect of this interfer-
ence on the mutation that ultimately prevails can be quite
pronounced, because those other clones that reach high
frequency tend to be strong competitors. To examine the
possible effects of clonal interference on the substitution
dynamics of the BoxG18A mutation, we performed pair-
wise competitions between ten clones that were isolated
at generation 1000 from this population, five carrying the
beneficial BoxG18A  allele and five with the ancestral
BoxG17A allele. From each clone, we then isolated a spon-
taneous Ara+ mutant; such mutations have been shown to
be effectively neutral in the glucose-limited environment
used in the long-term evolution experiment, but they
allowed us to distinguish the competitors by plating on
TA indicator plates. Each BoxG18A clone was competed
with each BoxG17A clone, with 2-fold replication corre-
sponding to the reciprocal Ara marker states, for a total of
50 competitions. The grand mean fitness of BoxG18A
clones relative to BoxG17A clones was only 1.0075, which
indicates an advantage of less than 1%. Although the
BoxG18A clones were slightly more fit, this advantage is far
smaller than the ~5% advantage measured relative to the
ancestor. These data imply strong interference from com-
peting clones that carry other beneficial mutations with
the spread of the BoxG18A mutation.
Sequencing glmUS promoter region in other evolved lines
Having discovered the BoxG18A mutation in our focal
population and shown that it was beneficial, this element
and the entire glmUS promoter region became a logical
candidate region for sequencing in the other 11 popula-
tions founded with the same ancestral strain and propa-
gated in the same environment. We sequenced the glmUS
promoter region in clones sampled at 10,000 and 20,000
generations from all of the populations. The focal popula-
tion retained the BoxG18A allele at generation 20,000.
However, all 11 other populations still had the ancestral
sequence at both time points. Evidently, only one popula-
tion substituted this particular mutation, although all 12
populations achieved substantial fitness gains during the
experiment [17,18].
Discussion
Chance and necessity
We began this paper by noting the tension between the
roles of chance and necessity in evolution. We sought to
address this issue by finding a beneficial mutation in one
long-term experimental population of E. coli, without
relying on any candidate loci, and then sequencing the
region in other replicate populations to determine
whether they had substituted the same or similar muta-
tions. We found a beneficial mutation in the BoxG1 pro-
tein-binding site located near the P1 promoter of the
glmUS operon. The mutation was a 1-bp insertion of an
adenine in a tract of seven existing adenines. The muta-
tion spread in its source population between generation
500, when it was rare or absent, and generation 1500,
when it was present in almost every cell. The mutation
persisted through 20,000 generations. It conferred a sub-
stantial fitness advantage, on the order of 5%, when trans-
duced into the ancestor.BMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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We also sequenced the region upstream of glmUS in 11
replicate populations. These other populations were
founded by the same ancestor, and were propagated for
20,000 generations in the same environment, as the pop-
ulation that had evolved the BoxG18A beneficial mutation.
Moreover, these replicate populations all had substantial
fitness gains of similar magnitude to the gain measured in
the population that substituted the BoxG18A  allele
[17,18]. However, none of 11 other populations evolved
a change in BoxG1 nor anywhere else in the region
upstream of the glmUS  operon. Several other adaptive
changes have occurred in only one of the replicate popu-
lations [47,48]. These findings illustrate the unpredicta-
bility of evolution, not merely at the level of random drift
of neutral mutations, but instead with respect to adapta-
tion. In striking contrast to these unique events, however,
many changes in the evolving populations involve
repeated beneficial mutations in the same genes [11-
13,21-23,28]. Taken together, these cases nicely demon-
strate that adaptation by natural selection can be both pre-
dictable and unpredictable in the same experiment.
It is interesting to consider two alternative hypotheses for
why a BoxG1 mutation was substituted in only one of 12
replicate populations, despite its substantial advantage in
the ancestral genetic background. According to one
hypothesis, there have not been enough cell generations
in each population for the same mutation to have
occurred in the other populations. According to the other
hypothesis, different mutations were substituted in the
replicate populations that rendered this particular muta-
tion no longer advantageous. The former hypothesis cap-
tures the idea of chance in its simplest sense of individual
stochastic events. The latter explanation adds historical
contingency, such that the likelihood of a particular out-
come is conditional on whether some other event has
already occurred [47].
The following quantitative considerations argue against
the adequacy of the first and simpler hypothesis. The size
of each population fluctuated between about 5 × 106 and
5 × 108  cells, owing to the daily dilution into fresh
medium and re-growth. The effective population size with
respect to new beneficial mutations escaping extinction by
random drift is approximately equal to the minimum size
multiplied by the number of generations between mini-
mum and maximum sizes [16]: 5 × 106 × log2 100 ≈ 3 ×
107 cells. The mutation rate in E. coli has been estimated
to be 5 × 10-10 per bp by Drake [49], although the substi-
tution rate of synonymous mutations in the long-term
experiment yields a somewhat lower estimate of 1.5 × 10-
10 [26,28]. Even using this lower rate estimate and the
effective population size, and with three alternative base-
pairings at each site, one expects that during 20,000 gen-
erations the average mutation has occurred (3 × 107) ×
(1.5 × 10-10/3) × (2 × 104) = 30 times. The 1-bp insertion
of an adenine into an existing tract of seven adenines in
the BoxG1 element is likely to have occurred more often,
because homopolymeric tracts are very prone to inser-
tions and deletions resulting from strand slippage during
replication [50,51]. Moreover, several of the long-term
populations evolved defects in their DNA repair, causing
much higher mutation rates [18,26,52]. Of course, many
beneficial mutations are lost by random drift while they
are rare. The probability of a beneficial mutation being
lost by drift is approximately 1 - 2s, where s is its selective
advantage [44,53]. Thus, a mutation that confers a 5%
advantage, such as the one in BoxG1, is expected to be lost
by drift ~90% of the time. Even so, one would expect such
a mutation to have appeared and survived drift multiple
times in each population. Yet, the BoxG18A mutation was
substituted in only 1 of the 12 evolving populations.
How can we explain its absence from the other popula-
tions? The best explanation, in our view, relies on the
effects of clonal interference and epistasis, which together
give rise to the historically contingent form of chance. In
an asexual population, such as in the long-term experi-
ment, two clones that acquire different beneficial muta-
tions will compete with one another, and only one can
ultimately prevail. Owing to this clonal interference,
many beneficial mutations that escape drift nonetheless
will be lost in competition with superior mutations
[44,45]. We showed that clonal interference impeded the
rate of spread of the BoxG18A mutation even in the popu-
lation in which it was substituted. Although clonal inter-
ference might explain the failure to observe this mutation
in the other populations, we doubt that it alone suffices.
The likelihood that a given beneficial mutation will be
eliminated by clonal interference depends on its advan-
tage relative to other beneficial mutations still being gen-
erated in the evolving population [44]. Early in the long-
term evolution experiment, a number of mutations with
benefits on the order of 10% spread through all of the
populations, and these could have interfered with the sur-
vival of the BoxG18A mutation [16,17]. However, the rate
of fitness improvement declined sharply after the first
2000 generations [17,18,54]. Therefore, later appearances
of the BoxG18A mutation would not have encountered
many superior beneficial mutations, assuming that the
BoxG18A mutation itself would still have conferred a ~5%
advantage in these evolved genetic backgrounds. Yet,
these BoxG18A mutations were not seen, even much later,
in the other 11 populations. This absence suggests, there-
fore, that mutations in other genes were substituted that
rendered the BoxG18A mutation less advantageous, neu-
tral, or even disadvantageous. That is, some other muta-
tions may interact epistatically with the BoxG18A
mutation, such that their combined benefits are less than
expected from their individual effects. After one of theseBMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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other mutations had been substituted in a population, the
likelihood of a BoxG18A  mutation being substituted
would therefore be reduced or eliminated.
Mode of action of the BoxG1 beneficial mutation
Our experiments demonstrate that the BoxG18A allele is
beneficial in the ancestral background in the glucose-lim-
ited medium. The mutation is located in the upstream reg-
ulatory region of the glmUS operon, which encodes two
proteins involved in the synthesis of peptidoglycan and
other cell-wall components. The BoxG1 motif has been
shown previously to be a NagC protein-binding site that
affects the transcription of nearby genes [31].
Individual E. coli cells become larger as they grow faster
[55-57], and the glucose concentration used in the long-
term experiment permitted growth at a rate that was
extravagant compared with the natural environments in
which this species evolved for millions of years prior to
our evolution experiment [58]. Given the geometric fact
that the ratio of surface area to volume is reduced in larger
cells, it may have been beneficial for cells to produce
reduced amounts of cell-wall constituents in this experi-
ment. And given the role of GlmS and GlmU in producing
these components, one might expect the BoxG18A allele to
be associated with reduced expression of this operon.
Indeed, a comparison of the BoxG18A sequence with the
consensus Box sequence suggests reduced binding by the
NagC activator of glmUS  expression. Moreover, whole-
genome expression profiles showed that evolved clones
from this population, when growing exponentially in the
same conditions of the long-term experiment, had con-
sistently reduced mRNA levels for both glmU and glmS rel-
ative to the ancestor. Thus, the BoxG18A allele in the long-
term evolution experiment evidently leads to reduced
expression of the glmUS operon, which might provide a
better balance between the synthesis of cell-wall and other
cellular components.
As an added benefit, the end product of GlmS and GlmU
catalysis is UDP-GlcNAc, a precursor to peptidoglycan (as
well as other cell-wall components). The next step in pep-
tidoglycan production is the transfer of enolpyruvate from
phosphoenolpyruvate (PEP) to UDP-GlcNAc [32,33].
PEP is important not only as a precursor metabolite but
also as the source of the high-energy phosphate that drives
the phosphotransferase system (PTS), by which glucose is
actively transported into the cell [59]. All else equal,
reductions in the expression of glmUS and synthesis of
UDP-GlcNAc should leave more PEP available for driving
the PTS and thereby acquiring glucose, the sole available
source of carbon and energy in the long-term experiment.
Consistent with the importance of PEP in this experiment,
the population that evolved the BoxG18A allele later also
substituted an IS150 insertion into pykF, which encodes
an enzyme catalyzing the conversion of PEP to pyruvate
[25]. This insertion presumably disrupts PykF function,
causing the accumulation of PEP that could be used to
drive the PTS-mediated acquisition of glucose. In addition
to its advantage in medium containing glucose, the
BoxG18A mutation has significant effects on competitive-
ness in media containing fructose, GlcN6P, GlcN, and
mannose, possibly through NagC-mediated effects on
sugar transport and catabolism genes.
All 12 populations in the long-term experiment evolved
larger cell size, but only the Ara-1 population substituted
a mutation anywhere in the upstream regulatory region of
the glmUS operon. However, several populations, includ-
ing Ara-1, substituted mutations either in the pbpA gene or
near the promoter of pbpA-rodA, another operon involved
in peptidoglycan production and cell-wall elongation
[13,19,21]. Moreover, mutations in two additional genes
involved in cell-wall synthesis, mrdB and mreB, rose to
intermediate frequency in the Ara-1 population in the first
2000 generations, before they were eliminated, presuma-
bly by clonal interference [27]. Thus, although the substi-
tution in glmUS  is unique to the Ara-1 population,
beneficial mutations in other genes encoding related func-
tions arose in many of the replicate populations.
In contrast to our explanation, Graña and Acerenza [20]
proposed a model in which the parallel increases in cell
size and growth rate of these long-term populations were
both consequences of diverting intracellular resources
from unnecessary physiological functions to those that
enhanced performance in the glucose-only regime.
According to the model, beneficial mutations need not
have a direct role in cell-wall synthesis in order to impact
cell size. However, their model and our explanation are
not mutually exclusive. In fact, the evolution of faster
growing and larger cells caused by loss or repression of
unneeded functions should intensify the selection to
reduce the relative production of cell-wall components,
owing to the lower surface-to-volume ratio.
Conclusions
In this study, we sought to discover and characterize one
of the beneficial mutations responsible for the evolution-
ary adaptation in one of 12 E. coli populations grown for
20,000 generations in glucose-supplemented minimal
medium. We then wanted to see whether the same or a
similar mutation had occurred in the other populations,
in order to examine the roles of chance and necessity in
adaptive evolution. Our strategy employed transposon-
tagging an evolved clone's genome followed by transduc-
tion into the ancestor, screening for increased cell size and
fitness, co-transduction analysis, and sequencing the rele-
vant region in the focal and other populations. Our main
conclusions are as follows:BMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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1) We found a 1-bp insertion in the BoxG1 region located
in one of two operators of glmUS, an operon involved in
synthesizing peptidoglycan and other components of the
cell wall. The BoxG1 element has been shown previously
to bind NagC, which activates this promoter during
growth on glucose.
2) This mutation spread through the focal population
between generations 500 and 1500. When transduced
into the ancestral background, the BoxG18A  allele
increased competitive fitness by about 5%.
3) Expression profiles of ancestral and evolved clones
from the focal population show a reduction of almost
10% in glmUS expression associated with the substitution
of the BoxG18A allele. The insertion of the extra base-pair
into the BoxG1 site apparently reduces NagC binding and
thereby the activity of the P1 promoter during growth on
glucose.
4) Faster growing cells are larger and, consequently, have
reduced surface-to-volume ratios; therefore, they have
proportionately less need for cell-wall components. The
BoxG1 mutation and reduced expression of glmUS may
thus confer an advantage by reducing excess synthesis of
these components. Also, the end-product of GlmS and
GlmU catalysis is UDP-GlcNAc, a precursor to peptidogly-
can. The next step in the production of peptidoglycan con-
sumes PEP, which would otherwise be available to drive
PTS-mediated glucose transport.
5) Despite the large fitness gain conferred by the BoxG18A
allele in the environment in which it arose, no similar
mutations were found upstream of the glmUS operon in
any of the other 11 replicate populations, even after
20,000 generations. A possible explanation is that those
populations substituted mutations at other loci that inter-
act epistatically with the glmUS operon, so that mutations
in the BoxG1 region would no longer confer a substantial
benefit. In fact, mutations in another operon involved in
cell-wall synthesis arose in a number of replicate popula-
tions, including the focal population with the glmUS
mutation. In any case, the unique substitution at the
BoxG1 site illustrates the unpredictability of adaptive evo-
lution, whereas parallel substitutions at other loci in these
same populations illustrate its predictability.
Methods
Bacterial strains and culture conditions
The bacteria used in this study are part of a long-term evo-
lution experiment that has been described in detail else-
where [16-18]. Briefly, 12 populations of Escherichia coli B
were started, six from each of two genetically marked var-
iants of the ancestor. The populations were propagated by
1:100 daily serial transfer in Davis minimal medium sup-
plemented with glucose at 25 μg per ml (DM25) at 37°C
for 20,000 generations (3000 days). The two ancestral var-
iants, REL606 and REL607, are phenotypically Ara- and
Ara+, respectively. These variants are selectively neutral in
DM25 medium, but Ara- and Ara+ genotypes can be distin-
guished by their red and white colonies, respectively, on
tetrazolium-arabinose (TA) indicator agar. At 500-genera-
tion intervals, samples from each population were stored
at -80°C.
The source of the beneficial BoxG18A mutation that is the
focus of this paper is a clone, REL4548, that was isolated
from population Ara-1 at generation 10,000. This popula-
tion retained functional DNA repair throughout the first
20,000 generations of the evolution experiment, whereas
several other populations became hypermutable as a con-
sequence of mutations that disrupted repair functions
[18,52]. The Ara-1 population also subsequently evolved
a mutator phenotype, but did so only after the 20,000
generations examined in this study [27,28]. REL10247 is
the designation of a P1-transductant clone that was
derived using REL4548 as the donor and REL606 as the
recipient. The REL10247 genome has a mini-transposon
bearing a tetracycline resistance (Tetr) marker inserted 20
bp downstream from the last codon in the glmUS operon;
and a 1-bp adenine insertion in a tract of seven pre-exist-
ing adenines in the BoxG1 site of the glmUS promoter
region. It has no other mutational differences from the
ancestor within ~6,000 bp on either side of the mini-
transposon. However, it has a deletion of the rbs operon
[11] that begins ~18,000 bp from the BoxG1 site (in the
direction opposite from the mini-transposon), which was
co-transduced from REL4548. We describe later the con-
struction of another strain, TC640, that carries the evolved
BoxG18A allele but is otherwise isogenic to the ancestor.
When sequencing BoxG1 and the rest of the region
upstream of the glmUS operon, we chose clones at ran-
dom from the frozen samples of the Ara-1 population
taken at various time points, as well as from samples of
the other 11 populations at generations 10,000 and
20,000.
Strain JM109 and plasmid pUC19 were obtained from
New England Biolabs and used in certain genetic manip-
ulations described below.
Mini-transposon tagging
The protocol that we used to produce a library of clones
carrying mini-transposons and associated markers follows
the one developed by Kleckner et al. [60]. Phage λNK1323
was used as the delivery vector for inserting mini-Tn10
transposons that confer tetracycline resistance into
REL4548. We made 1296 independent insertion mutants.
These mutants were used to inoculate individual 2-ml cul-BMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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tures of LBC supplemented with 15 μg/ml Tet, which were
grown overnight at 37°C. This number of insertion
mutants is such that, in a genome of ~4.6 × 106 bp [30], a
marker should occur, on average, every ~3600 bp. The
1296 cultures were then mixed in equal volume to pro-
vide a proportional representation of each marked clone.
Glycerol was added to 16%, and this mixture, designated
MIX-1, was frozen at -80°C for later use in producing the
P1-transducing lysate.
P1-mediated transduction and co-transduction
Following a standard protocol [61], phage P1
(ATCC25404-B1) was grown on MIX-1 to produce a lysate
stock (LYS-1) that was then used to transduce the ances-
tral strain REL606. An aliquot of the transduced culture
was plated on LB agar containing 15 μg/ml Tet to estimate
the total number of Tetr transductants. The remaining cul-
ture was added to 200 ml LB supplemented with 15 μg/ml
Tet, allowed to grow overnight, then frozen at -80°C in
16% glycerol. This frozen culture, designated MIX-2, thus
contained a diverse mix of genotypes. These genotypes
consist of randomly-tagged DNA from the evolved clone
REL4548 bearing a mini-transposon along with any phys-
ically linked DNA sequences, inserted into the ancestral
REL606 background. P1 phage transfers only ~2% of the
E. coli genome between donor and recipient strains.
Another clone sampled from the same population and
generation has a total of 28 mutations distributed
throughout its sequenced genome [28], and so one would
expect that most transductants in the MIX-2 culture carry
no more than 1 or 2 mutations.
We also performed a second round of transduction to esti-
mate the physical distance between the beneficial muta-
tion and the mini-transposon marker, based on their co-
transduction. A P1-transducing lysate was prepared from
REL10247 using the same methods as above. This lysate,
designated LYS-2, was used to transduce the ancestral
strain REL606. A random sample of the Tetr transductants
was screened for cell size, and some transductants were
also used in fitness assays.
Enrichment procedure to find beneficial transductant
To facilitate finding a clone that carried a beneficial muta-
tion linked to a transposon-encoded marker, we serially
propagated the MIX-2 mixture of transductants in the
same DM25 medium and other culture conditions as used
in the long-term evolution experiment. This procedure
was performed for 7 daily cycles, corresponding to ~47
cell generations. Glycerol was then added to the resulting
culture, designated MIX-3, which was stored at -80°C.
Construction of isogenic mutant strain by gene gorging
To determine the phenotypic effects caused specifically by
the BoxG18A mutation, we used the gene-gorging method
[34] to move this mutation into the ancestral genome,
producing a new strain designated TC640. Primers were
designed to amplify a 1280-bp product centered on the
BoxG18A mutation, one of which also contained the I-SceI
homing endonuclease recognition site required for the
gene gorging protocol. These primers were used to
amplify a product from REL4548, the 10,000-generation
clone from which REL10247 was derived. This product
was cloned into pCR2.1 to make a gene-gorging mutagen-
esis plasmid. Subsequent manipulations followed the pre-
vious protocol [34], except LB was used instead of rich
defined medium. Successful transfer of the BoxG18A muta-
tion was confirmed by direct sequencing. To ensure that
no other mutations were inadvertently introduced during
construction of TC640, we then also replaced the BoxG18A
mutation with the ancestral operator sequence. The fit-
ness of this reverted strain in glucose medium was indis-
tinguishable from the ancestor (data not shown), which
strongly implies that no secondary mutations affecting fit-
ness were present in the intermediate strain, TC640.
Screening for cell size
Previous research has shown a strong, positive correlation
between cell volume and relative fitness in the evolving
population studied here [17,19]. Moreover, cell size can
be measured more easily and precisely than relative fit-
ness. Therefore, we chose to focus on clones from MIX-3
that produced cells with significantly larger volumes than
those produced by the ancestor REL606. Clones from
MIX-3 were isolated on LB plates containing 15 μg/ml Tet,
then propagated for two daily transfers in DM25 at 37°C.
Average cell volumes were measured using a Coulter par-
ticle counter (model ZM and channelyzer model 256).
The ancestor produces an average cell size of 0.37-0.39 fl,
depending on the experiment, whereas the clones we
chose for further study had average cell sizes of at least
0.44 fl. For the co-transduction analysis using REL10247
as donor and the ancestor as recipient, we scored Tetr
clones with average cell volumes ≥0.44 fl as having the
beneficial allele, and those with averages ≤0.39 fl as hav-
ing the ancestral allele; intermediate values were ignored
when estimating the co-transduction frequency.
Fitness assays
Competition experiments were performed to estimate the
relative fitness of various clones. The procedures for the
assays have been described in detail elsewhere [16]. In
brief, two competing clones, one Ara- and the other Ara+,
are separately acclimated to the conditions in which they
will compete, and then mixed at a 1:1 volumetric ratio in
the competition environment. Samples are plated on TA
agar immediately after mixing and again at the end of the
competition experiment. The competitions ran for one
complete serial-transfer cycle, which encompasses the
same lag, growth, and stationary phases that occur in theBMC Evolutionary Biology 2009, 9:302 http://www.biomedcentral.com/1471-2148/9/302
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long-term evolution experiment. Relative fitness is
defined simply as the ratio of the net growth rates realized
by the two strains during their competition [16].
Unless otherwise indicated, competitions involving par-
ticular clones of interest were performed against REL607,
the Ara+ ancestral strain. The competitions performed to
study clonal interference used pairs of evolved clones,
with spontaneous Ara+ mutants having been obtained for
each clone (on minimal arabinose agar) and the competi-
tion experiments balanced with respect to the Ara marker.
Also unless otherwise noted, experiments were performed
in DM25 medium, in which glucose at 25 μg/ml is the
only usable source of carbon. To investigate the physio-
logical effects of the BoxG18A mutation, additional com-
petitions of TC640 against REL607 were performed in the
same minimal medium except replacing the glucose with
fructose, GlcN, GlcN6P, mannose, or UDP-GlcNAc. For
UDP-GlcNAc only, the amount of resource was reduced to
8.75 μg/ml to equalize the available carbon.
Southern blots
Plasmid pNKtet [60] was digested with BglI and XbaI, and
the fragment containing the tetracycline-resistance gene
was used as a probe. Genomic DNA of the clone desig-
nated REL10247 was isolated from an overnight LB cul-
ture using the Qiagen Genomic-tip system. A number of
restriction enzymes were then used to digest this genomic
DNA, including AvaI, BamHI, PvuI, and PvuII. Five μg of
DNA were cut with 40 units of each restriction enzyme.
The samples were run on a 0.5% agarose TBE gel, and then
blotted onto a positively charged nylon membrane (Boe-
hringer Mannheim) using a vacuum. Southern hybridiza-
tion was performed using the DIG DNA Labelling and
Detection Kit (Boehringer Mannheim) and the manufac-
turer's recommendations. The lane containing the AvaI-
digested genomic DNA produced a band of ~5500 bp
containing the entire functional tetracycline-resistance
marker [60] as well as flanking DNA. The size of this frag-
ment made it suitable to clone it and then sequence the
genomic DNA flanking the mini-transposon.
Mapping and sequencing
To map the chromosomal location of the mini-transpo-
son inserted in the REL10247 genome, the ~5500 bp AvaI
fragment was excised, purified, cloned into pUC19, and
used to transform JM109. Prior to ligation, the AvaI-
digested vector was treated with alkaline phosphatase
(Gibco BRL) following the manufacturer's recommenda-
tions for 5' overhangs. The ligation was performed at
16°C for 16 h after a 5' treatment at 45°C. Following
transformation of JM109, a Tetr clone was isolated on an
LB plate containing 15 μg/ml Tet. The DNA insert was
sequenced using M13/pUC forward and reverse primers.
A BLAST search was used to locate the site of the transpo-
son insertion. The RL100 primer (5'-CGGATCCGATCAT-
ATGACAAGATGTGTA-3') was used specifically for the
junction between the transposon and the E. coli genome.
Primers and PCR
We sequenced regions around the mini-transposon inser-
tion via chromosome walking, in order to find the benefi-
cial mutation that was co-transduced with the insertion in
REL10247. To that end, genomic DNA was isolated from
REL606 and REL10247. PCRs were then used to generate
four partially overlapping fragments, ranging in size from
~3400 to ~4100 bp, which were purified using an Ultra-
free-MC filter (Millipore) or an Elu-Quik DNA Purifica-
tion Kit (Schleicher & Schuell). The PCR fragments were
sequenced on each end, and new sequencing primers were
designed at the 3' end of the prior sequencing run.
Sequencing continued until both ends overlapped. The
glmUS promoter region was sequenced on both strands
using primer RL36 (positive strand: 5'-ATTTTCTGCA-
GACAAAAGGCGTGAC-3') and RL51 (negative strand: 5'-
GTTCTCGGTGGTGCGGATAACAAT-3').
Some of our experiments involved sequencing the glmUS
promoter region from many clones. These PCRs used
primers RL32 (5'-GTTCTGGCCGACACCGCAAT-3') and
RL35 (5'-GCAGTTTTTCAGCCTGTTCGGACT-3').
Sequence data were managed using the DNASTAR soft-
ware (Madison, Wisconsin).
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